We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Nanoplastics cause an increased risk of Parkinson’s disease compared to microplastics at environmental exposure levels
AI summary Read the abstract
Mice that breathed in tiny nanoplastic particles for 16 weeks showed more brain changes linked to Parkinson's disease, such as nerve cell damage and inflammation, than mice exposed to larger microplastic particles. Behavioral problems were also greater in the nanoplastic group, even though the amount reaching the brain was very small.
Recent evidence suggests a potential link between airborne microplastics (MP) and nanoplastics (NP) and neurodegenerative diseases, yet direct in vivo demonstration of their neurotoxicity remains limited. This study aimed to assess the potential risk of Parkinson’s disease (PD) associated with chronic inhalation exposure to polystyrene nanoplastics (PS-NP), by examining PD-relevant behavioral and neuropathological alterations compared to polystyrene microplastics (PS-MP). Adult mice were exposed daily to 100 ppm/200 µL of 20 nm PS-NP or 0.25 µm PS-MP via inhalation for 16 weeks. Brain uptake and exposed dose were quantified using 64 Cu-labeled PS and gamma counting. Behavioral assessments, histology, immunohistochemistry, western blotting, and RNA sequencing were performed to evaluate PD-relevant outcomes. Only 0.094 % of the estimated human-equivalent environmental dose was exposed to the substantia nigra and striatum. PS-NP exposure induced greater behavioral deficits compared to PS-MP. RNA-seq revealed dysregulation of PD-related genes, overlapping with those in MPTP-induced PD models. Western blot and immunohistochemistry confirmed reduced tyrosine hydroxylase, increased phospho-α-synuclein (Ser129) aggregation, and elevated markers of glial activation (GFAP, IBA1) and pro-inflammatory cytokines in the PS-NP group. Inhaled PS-NP induced PD-relevant neuropathological and behavioral changes, suggesting that chronic exposure may contribute to increased PD risk under environmentally realistic conditions. These findings emphasize the need to evaluate airborne NP exposure as a novel environmental risk factor for PD.
More Papers Like This
Long-term low-dose nanoplastic exposure induces neurotoxicity with oxidative brain damage
AI summary Read the abstract
Scientists exposed mice to tiny plastic particles (nanoplastics) at low doses over 17 months—mimicking the kind of gradual exposure humans might get from everyday plastic use—and found it caused brain inflammation, oxidative damage, and activated genetic pathways linked to diseases like Parkinson's. While the mice didn't show major behavior changes, this study suggests that even small, ongoing amounts of plastic exposure over time could quietly harm brain health, reinforcing why reducing plastic exposure in daily life may be worth considering. More research is needed to confirm whether these effects translate to humans
Micro-nanoplastics and Parkinson’s disease: evidence and perspectives
AI summary Read the abstract
Researchers reviewed growing evidence linking micro- and nanoplastic exposure to Parkinson's disease, a degenerative brain condition. Lab studies suggest these particles may accelerate disease by promoting the misfolding of a key brain protein (alpha-synuclein), triggering inflammation, and damaging mitochondria — though large-scale human studies are still needed to establish causation and define safe exposure thresholds.
Micro- and nanoplastics as environmental modifiers of neuroimmune dysfunction in Parkinson's disease
AI summary Read the abstract
This review paper looks at how tiny plastic particles from pollution—called micro- and nanoplastics—might build up in the brain and trigger inflammation and immune system problems linked to Parkinson's disease. While scientists haven't yet proven that these plastics actually cause Parkinson's in humans, the research so far suggests they could act as a stress factor that makes the brain more vulnerable to damage, especially through effects on brain cells and the gut-brain connection. This matters because it highlights another reason to think about reducing everyday plastic exposure, even though more direct human studies are needed before drawing firm conclusions.
Nanoplastics exacerbate Parkinson's disease symptoms in C. elegans and human cells
AI summary Read the abstract
Researchers discovered that tiny 25-nanometer plastic particles worsened symptoms similar to Parkinson's disease in both worm models and human cells, including nerve cell death, movement problems, and buildup of harmful protein clumps. The nanoplastics also damaged the intestinal barrier, causing a "leaky gut" condition, and broke apart mitochondria in muscle cells. These findings suggest nanoplastic exposure could be a risk factor for neurodegenerative diseases.
Microplastics and Nanoplastics as Potential Contributors to Neurodegenerative Disease: Mechanistic Links to Dementia, Parkinson's Disease, Epilepsy, and Emerging Therapeutic Opportunities
AI summary Read the abstract
Researchers review how microplastics and nanoplastics may reach the brain via inhalation and systemic routes, proposing that chronic neuroinflammation, oxidative stress, and direct interactions with proteins like amyloid-β and α-synuclein could link particle exposure to Alzheimer's, Parkinson's, and other neurodegenerative conditions.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.